Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
OPINION
Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years
By Brian Sozzi
Mar 14, 2018 6:23 PM EDT
PRESS RELEASES
ChemoCentryx Appoints Tausif ('Tosh') Butt As Executive Vice President And Chief Operating Officer
By GlobeNewswire
Feb 24, 2021 8:30 AM EST
PRESS RELEASES
ChemoCentryx To Hold Fourth Quarter And Full Year 2020 Financial Results Conference Call on Monday, March 1, 2021
By GlobeNewswire
Feb 23, 2021 8:30 AM EST
PRESS RELEASES
ChemoCentryx Announces Publication In The New England Journal Of Medicine Of Results Of The Pivotal Phase III ADVOCATE Trial Of Avacopan For The Treatment Of ANCA-Associated Vasculitis
By GlobeNewswire
Feb 17, 2021 5:00 PM EST
PRESS RELEASES
ChemoCentryx To Participate In Two Upcoming Investor Conferences
By GlobeNewswire
Jan 6, 2021 8:30 AM EST
PRESS RELEASES
ChemoCentryx To Present At Two Upcoming Investor Conferences
By GlobeNewswire
Nov 19, 2020 8:30 AM EST
PRESS RELEASES
ChemoCentryx Announces Plenary Session At ACR Convergence 2020 To Highlight Findings Of ADVOCATE Phase III Trial In ANCA-Associated Vasculitis
By GlobeNewswire
Nov 6, 2020 8:30 AM EST
PRESS RELEASES
ChemoCentryx To Hold Third Quarter 2020 Financial Results Conference Call On Monday, November 9, 2020
By GlobeNewswire
Nov 2, 2020 8:30 AM EST
PRESS RELEASES
ChemoCentryx Announces FDA Acceptance Of The Avacopan New Drug Application (NDA) For The Treatment Of ANCA-Associated Vasculitis
By GlobeNewswire
Sep 17, 2020 8:30 AM EDT
PRESS RELEASES
ChemoCentryx To Present At The H.C. Wainwright 22nd Annual Global Investment Conference
By GlobeNewswire
Sep 8, 2020 8:30 AM EDT
PRESS RELEASES
ChemoCentryx To Present At Two Upcoming Investor Conferences
By GlobeNewswire
Aug 4, 2020 8:30 AM EDT
PRESS RELEASES
ChemoCentryx To Hold Second Quarter 2020 Financial Results Conference Call On Monday, August 10, 2020
By GlobeNewswire
Aug 3, 2020 8:30 AM EDT
PRESS RELEASES
ChemoCentryx Submits New Drug Application To The U.S. FDA For Avacopan In ANCA-Associated Vasculitis
By GlobeNewswire
Jul 9, 2020 8:30 AM EDT
PRESS RELEASES
ChemoCentryx Identifies Novel Orally Administered Immune Checkpoint Inhibitor CCX559 For Next Generation Cancer Treatment
By GlobeNewswire
Jun 24, 2020 8:30 AM EDT
PRESS RELEASES
ChemoCentryx Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares
By GlobeNewswire
Jun 15, 2020 4:05 PM EDT
PRESS RELEASES
ChemoCentryx Prices Public Offering Of Common Stock
By GlobeNewswire
Jun 10, 2020 9:33 PM EDT
PRESS RELEASES
ChemoCentryx Announces Proposed Public Offering Of Common Stock
By GlobeNewswire
Jun 10, 2020 4:08 PM EDT
PRESS RELEASES
ChemoCentryx Phase III ADVOCATE Trial Of Avacopan In ANCA-Associated Vasculitis Highlighted In Oral Plenary Presentations At EULAR And ERA-EDTA Congresses
By GlobeNewswire
Jun 3, 2020 7:30 AM EDT
PRESS RELEASES
ChemoCentryx To Hold First Quarter 2020 Financial Results Conference Call on Monday, May 11, 2020
By GlobeNewswire
May 4, 2020 8:30 AM EDT
PRESS RELEASES
ChemoCentryx To Hold Fourth Quarter And Full Year 2019 Financial Results Conference Call on Tuesday, March 10, 2020
By GlobeNewswire
Mar 3, 2020 8:30 AM EST
PRESS RELEASES
ChemoCentryx To Present At The 9th Annual SVB Leerink Global Healthcare Conference
By GlobeNewswire
Feb 19, 2020 8:30 AM EST
OPINION
Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years
By Brian Sozzi
Mar 14, 2018 6:23 PM EDT
HEALTH
Biotech Premarket Movers: ChemoCentryx, Jazz, Ionis, Zogenix
By Armie Margaret Lee
Mar 10, 2017 9:29 AM EST
OPINION
These 5 stocks are poised for big breakouts
By Roberto Pedone
Apr 1, 2016 8:43 AM EDT
INVESTING
3 Stocks Under $10 Moving Higher
By Roberto Pedone
May 2, 2014 8:08 AM EDT
